Skip to content
healthcare.dev

NEUPOGEN

NDC 55513-530, Filgrastim, injection, solution, from Amgen, Inc.

Product NDC
55513-530
Status
Listed
Labeler
Amgen, Inc
Dosage form
INJECTION, SOLUTION
Route
INTRAVENOUS, SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA103353
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/55513-530 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • FILGRASTIM300 ug/mL

Pharmacologic classes

Granulocyte Colony-Stimulating Factor [CS]; Increased Myeloid Cell Production [PE]; Leukocyte Growth Factor [EPC]

Package NDCNDC-11Package
55513-530-105551305301010 VIAL in 1 PACKAGE (55513-530-10) / 1 mL in 1 VIAL (55513-530-01)
55513-530-205551305302010 VIAL in 1 PACKAGE (55513-530-20) / 1 mL in 1 VIAL (55513-530-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/97cc73cc-b5b7-458a-a933-77b00523e193
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=55513-530
  • NADAC price for package 55513053010

    GET /v1/drugs/nadac/55513053010
  • NADAC price for package 55513053020

    GET /v1/drugs/nadac/55513053020

Use it

Look up 55513-530 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/55513-530 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 55513-530. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.